Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy CEO bought 45,000 shares at an average $0.03 ($1,487)
  2. 4 Open-market buy President bought 21,000 shares at an average $0.02 ($498)
  3. 4/A Open-market buy CEO bought 20,601,123 shares at an average $0.02 ($852)
  4. 4 Open-market buy CEO bought 1,045,000 shares at an average $0.02 ($852)
  5. 4 Open-market buy President bought 8,200 shares at an average $0.02 ($154)
  6. S-1/A Offering Registration Statement
  7. S-1 Offering Registration Statement
  8. 4 Open-market buy President bought 41,100 shares at an average $0.02 ($772)
  9. 8-K Event Material agreement
  10. 4 Open-market buy President bought 30,500 shares at an average $0.02 ($605)
  11. 4 Open-market buy President bought 83,199 shares at an average $0.02 ($1,739)
  12. 4 Open-market buy President bought 138,000 shares at an average $0.02 ($2,543)
  13. 4 Open-market buy President bought 9,000 shares at an average $0.02 ($195)
  14. 4 Open-market buy President bought 17,000 shares at an average $0.02 ($375)
  15. 4 Open-market buy President bought 28,200 shares at an average $0.02 ($672)
  16. 4 Open-market buy President bought 26,600 shares at an average $0.03 ($782)
  17. 8-K Event Material agreement
  18. 4 Open-market buy President bought 34,100 shares at an average $0.03 ($964)
  19. 4 Open-market buy President bought 35,500 shares at an average $0.03 ($1,022)
  20. 4 Open-market buy President bought 20,000 shares at an average $0.03 ($589)

Page 8 of 26 · 502 filings